α-tocopheryl phosphate suppresses tumor invasion concurrently with dynamic morphological changes and delocalization of cortactin from invadopodia

International Journal of Oncology

Volumn 35, Issue 6, 2009, Pages 1277-1288

  Saitoh, Yasukazu ^a   Yumoto, Atsushi ^a   Miwa, Nobuhiko ^a  

^a PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

Author keywords

tocopheryl phosphate; Cortactin; Invadopodia; Invasion; Tumor cell

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOPHERYL PHOSPHATE; CORTACTIN; GELATINASE A; GELATINASE B; LIPID HYDROPEROXIDE; PEROXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; UNCLASSIFIED DRUG; ALPHA TOCOPHEROL PHOSPHATE; ALPHA-TOCOPHEROL PHOSPHATE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CELL ADHESION; CELL MOTILITY; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; DRUG STRUCTURE; EXTRACELLULAR MATRIX; FIBROSARCOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MEMBRANE FLUIDITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SKIN FIBROBLAST; WESTERN BLOTTING; CELL MOTION; DRUG EFFECT; METABOLISM; OXIDATIVE STRESS; PSEUDOPODIUM; SCANNING ELECTRON MICROSCOPY; TUMOR CELL LINE;

ALPHA-TOCOPHEROL; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CORTACTIN; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, SCANNING; OXIDATIVE STRESS; PSEUDOPODIA;

EID: 73949157951     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000445     Document Type: Article

References (66)

1. Gianello R, Libinaki R, Azzi A, et al: Alpha-tocopheryl phosphate: a novel, natural form of vitamin E. Free Radic Biol Med 39: 970-976, 2005.
2. Libinaki R, Ogru E, Gianello R, Bolton L and Geytenbeek S: Evaluation of the safety of mixed tocopheryl phosphates (MTP) - a formulation of alpha-tocopheryl phosphate plus alpha-ditocopheryl phosphate. Food Chem Toxicol 44: 916-932, 2006.
3. Rezk BM, van der Vijgh WJ, Bast A and Haenen GR: Alphatocopheryl phosphate is a novel apoptotic agent. Front Biosci 12: 2013-2019, 2007.
4. Negis Y, Zingg JM, Ogru E, Gianello R, Libinaki R and Azzi A: On the existence of cellular tocopheryl phosphate, its synthesis, degradation and cellular roles: a hypothesis. IUBMB Life 57: 23-25, 2005.
5. Mukherjee S, Lekli I, Das M, Azzi A and Das DK: Cardioprotection with alpha-tocopheryl phosphate: amelioration of myocardial ischemia reperfusion injury is linked with its ability to generate a survival signal through Akt activation. Biochim Biophys Acta 1782: 498-503, 2008.
6. Nakayama S, Katoh EM, Tsuzuki T and Kobayashi S: Protective effect of alpha-tocopherol-6-O-phosphate against ultraviolet B-induced damage in cultured mouse skin. J Invest Dermatol 121: 406-411, 2003.
7. Rezk BM, Haenen GR, Van Der Vijgh WJ and Bast A: The extraordinary antioxidant activity of vitamin E phosphate. Biochim Biophys Acta 1683: 16-21, 2004.
8. Munteanu A, Zingg JM, Ogru E, et al: Modulation of cell proliferation and gene expression by alpha-tocopheryl phosphates: relevance to atherosclerosis and inflammation. Biochem Biophys Res Commun 318: 311-316, 2004.
9. Negis Y, Aytan N, Ozer N, et al: The effect of tocopheryl phosphates on atherosclerosis progression in rabbits fed with a high cholesterol diet. Arch Biochem Biophys 450: 63-66, 2006.
10. Ogru E, Libinaki R, Gianello R, et al: Modulation of cell proliferation and gene expression by alpha-tocopheryl phosphates: relevance to atherosclerosis and inflammation. Ann NY Acad Sci 1031: 405-411, 2004.
11. Shevde LA and Welch DR: Metastasis suppressor pathways - an evolving paradigm. Cancer Lett 198: 1-20, 2003.
12. Rasheed S, Nelson-Rees WA, Toth EM, Arnstein P and Gardner MB: Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33: 1027-1033, 1974.
13. Saitoh Y, Okayasu H, Xiao L, Harata Y and Miwa N: Neutral pH hydrogen-enriched electrolyzed water achieves tumor-preferential clonal growth inhibition over normal cells and tumor invasion inhibition concurrently with intracellular oxidant repression. Oncol Res 17: 247-255, 2008.
14. Liu JW, Nagao N, Kageyama K and Miwa N: Anti-metastatic effect of an autooxidation-resistant and lipophilic ascorbic acid derivative through inhibition of tumor invasion. Anticancer Res 20: 113-118, 2000.
15. Takahashi M, Shibata M and Niki E: Estimation of lipid peroxidation of live cells using a fluorescent probe, diphenyl-1-pyrenylphosphine. Free Radic Biol Med 31: 164-174, 2001.
16. Schrenzel J, Serrander L, Banfi B, et al: Electron currents generated by the human phagocyte NADPH oxidase. Nature 392: 734-737, 1998.
17. Sato Y and Rifkin DB: Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol 107: 1199-1205, 1988.
18. Tsuda K, Kimura K and Nishio I: Leptin improves membrane fluidity of erythrocytes in humans via a nitric oxide-dependent mechanism - an electron paramagnetic resonance investigation. Biochem Biophys Res Commun 297: 672-681, 2002.
19. Bohle AS and Kalthoff H: Molecular mechanisms of tumor metastasis and angiogenesis. Langenbecks Arch Surg 384: 133-140, 1999.
20. 3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species. J Cell Biochem 95: 955-969, 2005.
21. Weaver AM: Cortactin in tumor invasiveness. Cancer Lett 265: 157-166, 2008.
22. Condeelis J, Singer RH and Segall JE: The great escape: when cancer cells hijack the genes for chemotaxis and motility. Annu Rev Cell Dev Biol 21: 695-718, 2005.
23. Kline K, Lawson KA, Yu W and Sanders BG: Vitamin E and cancer. Vitam Horm 76: 435-461, 2007.
24. Qian M, Kralova J, Yu W, et al: c-Jun involvement in vitamin E succinate induced apoptosis of reticuloendotheliosis virus transformed avian lymphoid cells. Oncogene 15: 223-230, 1997.
25. Neuzil J, Svensson I, Weber T, Weber C and Brunk UT: alphatocopheryl succinate-induced apoptosis in Jurkat T cells involves caspase-3 activation, and both lysosomal and mitochondrial destabilisation. FEBS Lett 445: 295-300, 1999.
26. Neuzil J, Weber T, Schroder A, et al: Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements. FASEB J 15: 403-415, 2001.
27. Neuzil J, Zhao M, Ostermann G, et al: Alpha-tocopheryl succinate, an agent with in vivo anti-tumour activity, induces apoptosis by causing lysosomal instability. Biochem J 362: 709-715, 2002.
28. Neuzil J, Dong LF, Ramanathapuram L, et al: Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria. Mol Aspects Med 28: 607-645, 2007.
29. Szatrowski TP and Nathan CF: Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51: 794-798, 1991.
30. Behrend L, Henderson G and Zwacka RM: Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 31: 1441-1444, 2003.
31. Amstad P, Crawford D, Muehlematter D, Zbinden I, Larsson R and Cerutti P: Oxidants stress induces the proto-oncogenes, C-fos and C-myc in mouse epidermal cells. Bull Cancer 77: 501-502, 1990.
32. Storz P: Reactive oxygen species in tumor progression. Front Biosci 10: 1881-1896, 2005.
33. Zhang G, Miura Y and Yagasaki K: Suppression of adhesion and invasion of hepatoma cells in culture by tea compounds through antioxidative activity. Cancer Lett 159: 169-173, 2000.
34. Gunther S, Ruhe C, Derikito MG, Bose G, Sauer H and Wartenberg M: Polyphenols prevent cell shedding from mouse mammary cancer spheroids and inhibit cancer cell invasion in confrontation cultures derived from embryonic stem cells. Cancer Lett 250: 25-35, 2007.
35. Mukai M, Shinkai K, Tateishi R, Mori Y and Akedo H: Macrophage potentiation of invasive capacity of rat ascites hepatoma cells. Cancer Res 47: 2167-2171, 1987.
36. Nonaka Y, Iwagaki H, Kimura T, Fuchimoto S and Orita K: Effect of reactive oxygen intermediates on the in vitro invasive capacity of tumor cells and liver metastasis in mice. Int J Cancer 54: 983-986, 1993.
37. Maulik N: Redox signaling of angiogenesis. Antioxid Redox Signal 4: 805-815, 2002.
38. Kageyama K, Onoyama Y, Otani S, Matsui-Yuasa I, Nagao N and Miwa N: Enhanced inhibitory effects of hyperthermia combined with ascorbic acid on DNA synthesis in Ehrlich ascites tumor cells grown at a low cell density. Cancer Biochem Biophys 14: 273-280, 1995.
39. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M and Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44-84, 2007.
40. Liu JW, Nagao N, Kageyama K and Miwa N: Antimetastatic and anti-invasive ability of phospho-ascorbyl palmitate through intracellular ascorbate enrichment and the resultant antioxidant action. Oncol Res 11: 479-487, 1999.
41. Nagao N, Nakayama T, Etoh T, Saiki I and Miwa N: Tumor invasion is inhibited by phosphorylated ascorbate via enrichment of intracellular vitamin C and decreasing of oxidative stress. J Cancer Res Clin Oncol 126: 511-518, 2000.
42. Burton GW, Joyce A and Ingold KU: First proof that vitamin E is major lipid-soluble, chain-breaking antioxidant in human blood plasma. Lancet 2: 327, 1982.
43. Negis Y, Meydani M, Zingg JM and Azzi A: Molecular mechanism of alpha-tocopheryl-phosphate transport across the cell membrane. Biochem Biophys Res Commun 359: 348-353, 2007.
44. Wells A: Tumor invasion: role of growth factor-induced cell motility. Adv Cancer Res 78: 31-101, 2000.
45. Werb Z: ECM and cell surface proteolysis: regulating cellular ecology. Cell 91: 439-442, 1997.
46. Birkedal-Hansen H: Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7: 728-735, 1995.
47. Johnsen M, Lund LR, Romer J, Almholt K and Dano K: Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol 10: 667-671, 1998.
48. Mignatti P and Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161-195, 1993.
49. MacDougall JR and Matrisian LM: Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 14: 351-362, 1995.
50. Kahari VM and Saarialho-Kere U: Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 31: 34-45, 1999.
51. Weaver AM: Invadopodia: specialized cell structures for cancer invasion. Clin Exp Metastasis 23: 97-105, 2006.
52. Linder S: The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol 17: 107-117, 2007.
53. Gimona M, Buccione R, Courtneidge SA and Linder S: Assembly and biological role of podosomes and invadopodia. Curr Opin Cell Biol 20: 235-241, 2008.
54. Machesky L, Jurdic P and Hinz B: Grab, stick, pull and digest: the functional diversity of actin-associated matrix-adhesion structures. Workshop on invadopodia, Podosomes and focal adhesions in tissue invasion. EMBO Rep 9: 139-143, 2008.
55. Ayala I, Baldassarre M, Giacchetti G, et al: Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation. J Cell Sci 121: 369-378, 2008.
56. Myllykangas S, Bohling T and Knuutila S: Specificity, selection and significance of gene amplifications in cancer. Semin Cancer Biol 17: 42-55, 2007.
57. Rodrigo JP, Garcia LA, Ramos S, Lazo PS and Suarez C: EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res 6: 3177-3182, 2000.
58. Hui R, Ball JR, Macmillan RD, et al: EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival. Oncogene 17: 1053-1059, 1998.
59. Luo ML, Shen XM, Zhang Y, et al: Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer Res 66: 11690-11699, 2006.
60. Yuan BZ, Zhou X, Zimonjic DB, Durkin ME and Popescu NC: Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma. J Mol Diagn 5: 48-53, 2003.
61. Bryce NS, Clark ES, Leysath JL, Currie JD, Webb DJ and Weaver AM: Cortactin promotes cell motility by enhancing lamellipodial persistence. Curr Biol 15: 1276-1285, 2005.
62. Patel AS, Schechter GL, Wasilenko WJ and Somers KD: Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro. Oncogene 16: 3227-3232, 1998.
63. Kowalski JR, Egile C, Gil S, Snapper SB, Li R and Thomas SM: Cortactin regulates cell migration through activation of NWASP. J Cell Sci 118: 79-87, 2005.
64. Huang C, Liu J, Haudenschild CC and Zhan X: The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J Biol Chem 273: 25770-25776, 1998.
65. Lua BL and Low BC: Cortactin phosphorylation as a switch for actin cytoskeletal network and cell dynamics control. FEBS Lett 579: 577-585, 2005.
66. Boyle SN, Michaud GA, Schweitzer B, Predki PF and Koleske AJ: A critical role for cortactin phosphorylation by Abl-family kinases in PDGF-induced dorsal-wave formation. Curr Biol 17: 445-451, 2007.